PAVmed Inc reports results for the quarter ended in March - Earnings Summary

PAVmed

13/05/2024 23:38

* PAVmed Inc  PAVM.OQ  reported a quarterly adjusted loss of
$2.62​​ per share for the quarter ended in March, higher than
the same quarter last year, when the company reported EPS of
$-2.85.  The mean expectation of four analysts for the quarter
was for a loss of $1.67 per share. Wall Street expected
results to range from $-1.82 to $-1.48 per share.
    * Revenue rose 126.5% to $1.01 million from a year ago;
analysts
expected $1.05 million. 
    * PAVmed Inc's reported EPS for the quarter was a loss of
$2.62​.
    * The company reported a quarterly loss of $22.79 million.
    * PAVmed Inc shares had fallen by 0.9% this quarter and
lost 40.2%
so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 6.5%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "buy"

Wall Street's median 12-month price target for PAVmed Inc is
$6.50 
This summary was machine generated from LSEG data May 13 at
10:38 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -1.89          -2.62          Missed
 Dec. 31 2023      -1.89          -1.81          Beat
 Sep. 30 2023      -2.05          -2.40          Missed
 Jun. 30 2023      -2.85          -2.10          Beat